PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.\', \'Department of Pneumology and Intensive Care Medicine, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.\', \'Department of Diagnostic and Interventional Radiology, RWTH Aachen University, Aachen, Germany.\', \'Department of Intensive Care and Intermediate Care, RWTH Aachen University, Aachen, Germany.\', \'Labordiagnostisches Zentrum &, Department of Medical Microbiology, RWTH Aachen University, Aachen, Germany.\', \'Clinic for Cardiology, Angiology and Internal Intensive Medicine, Medical Clinic I, RWTH Aachen University, Aachen, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/ejh.13480
?:doi
?:hasPublicationType
?:journal
  • European journal of haematology
is ?:pmid of
?:pmid
?:pmid
  • 32593209
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.06
?:rankingScore_hIndex
  • 75
?:title
  • Favorable COVID-19 course despite significant comorbidities in a ruxolitinib-treated patient with primary myelofibrosis.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32593209>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32593209>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all